A main E17K substitution in the AKT1 gene was first identified by Carpten et al. in 2007 in breast cancers (8%), and to date, it was also reported in other solid tumors: colorectal (6%) and bladder cancers (5%) [10, 25]. Here, AKT1 is linked to breast cancer.